"Organophosphonates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
Descriptor ID |
D063065
|
MeSH Number(s) |
D02.705.429
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Organophosphonates".
Below are MeSH descriptors whose meaning is more specific than "Organophosphonates".
This graph shows the total number of publications written about "Organophosphonates" by people in this website by year, and whether "Organophosphonates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 1 | 2 |
2007 | 2 | 0 | 2 |
2010 | 0 | 1 | 1 |
2011 | 2 | 0 | 2 |
2012 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organophosphonates" by people in Profiles.
-
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers. J Med Chem. 2022 10 27; 65(20):13813-13832.
-
Quantification of Phosphonate Drugs by 1H-31P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice. Anal Chem. 2022 07 19; 94(28):10045-10053.
-
Aliphatic amines are viable pro-drug moieties in phosphonoamidate drugs. Bioorg Med Chem Lett. 2020 12 15; 30(24):127656.
-
Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiol. 2020 04; 15:389-400.
-
Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73. ChemMedChem. 2019 08 06; 14(15):1431-1443.
-
The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues. Molecules. 2019 Jul 09; 24(13).
-
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):369-381.
-
Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant. Pediatr Transplant. 2018 05; 22(3):e13141.
-
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. Biol Blood Marrow Transplant. 2017 Mar; 23(3):512-521.
-
SF2312 is a natural phosphonate inhibitor of enolase. Nat Chem Biol. 2016 Dec; 12(12):1053-1058.